Current Cancer Drug Targets

2.3(top 20%)

impact factor

1.6K(top 10%)

papers

50.9K(top 10%)

citations

101(top 5%)

h-index

2.3(top 20%)

impact factor

1.8K

all documents

53.2K

doc citations

153(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy	Current Cancer Drug Targets	2008	855
2	The Role of Snail in EMT and Tumorigenesis	Current Cancer Drug Targets	2013	688
3	The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications	Current Cancer Drug Targets	2008	685
4	Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives	Current Cancer Drug Targets	2011	671
5	P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives	Current Cancer Drug Targets	2013	320
6	Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action	Current Cancer Drug Targets	2003	318
7	Garlic [Allium sativum]: A Review of its Potential Use as an Anti-Cancer Agent	Current Cancer Drug Targets	2003	308
8	The Role of Fibroblast Growth Factors in Tumor Growth	Current Cancer Drug Targets	2009	305
9	Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation	Current Cancer Drug Targets	2003	302
10	MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting	Current Cancer Drug Targets	2005	285
11	The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy	Current Cancer Drug Targets	2009	265
12	Matrix Metalloproteinases as Therapeutic Targets in Cancer	Current Cancer Drug Targets	2005	253
13	Oxidative Stress and Cancer: The Role of Nrf2	Current Cancer Drug Targets	2018	250
14	How Do Microtubule-Targeted Drugs Work? An Overview	Current Cancer Drug Targets	2007	245
15	Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway	Current Cancer Drug Targets	2009	244
16	Sulfonamides and Sulfonylated Derivatives as Anticancer Agents	Current Cancer Drug Targets	2002	243
17	Structure and Functional Relationships of Hsp90	Current Cancer Drug Targets	2003	242
18	Clinical Trials with Oncolytic Adenovirus in China	Current Cancer Drug Targets	2007	240
19	The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development	Current Cancer Drug Targets	2004	240
20	Cytokines, Inflammation and Colon Cancer	Current Cancer Drug Targets	2011	239
21	Ribonucleotide Reductase Inhibitors and Future Drug Design	Current Cancer Drug Targets	2006	237
22	Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds	Current Cancer Drug Targets	2004	236
23	Induction of Apoptosis by Curcumin and Its Implications for Cancer Therapy	Current Cancer Drug Targets	2005	236
24	MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy	Current Cancer Drug Targets	2005	227
25	Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System	Current Cancer Drug Targets	2014	224
26	MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy	Current Cancer Drug Targets	2018	221
27	Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer	Current Cancer Drug Targets	2013	220
28	Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin	Current Cancer Drug Targets	2003	218
29	Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets	Current Cancer Drug Targets	2004	218
30	Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer	Current Cancer Drug Targets	2010	201
31	Cancer Therapy with ß-Lapachone	Current Cancer Drug Targets	2002	200
32	Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials	Current Cancer Drug Targets	2011	200
33	NSAIDs and Chemoprevention	Current Cancer Drug Targets	2004	199
34	Deregulation of the Akt Pathway in Human Cancer	Current Cancer Drug Targets	2008	199
35	Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance	Current Cancer Drug Targets	2012	196
36	Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy	Current Cancer Drug Targets	2005	190
37	Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response	Current Cancer Drug Targets	2007	187
38	The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors	Current Cancer Drug Targets	2003	186
39	NOTCH Signaling as a Novel Cancer Therapeutic Target	Current Cancer Drug Targets	2006	185
40	Oncorine, the World First Oncolytic Virus Medicine and its Update in China	Current Cancer Drug Targets	2018	178
41	Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-kappa B (NF-κB) and Activator Protein-1 (AP-1) in UVB-Induced Skin Carcinogenesis	Current Cancer Drug Targets	2007	169
42	Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy	Current Cancer Drug Targets	2004	169
43	Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy	Current Cancer Drug Targets	2009	165
44	AKT Signaling in Regulating Angiogenesis	Current Cancer Drug Targets	2008	163
45	Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development	Current Cancer Drug Targets	2004	162
46	Targeting Apoptosis Pathways in Cancer Therapy	Current Cancer Drug Targets	2004	158
47	Signal Transducers and Activators of Transcription (STATs): Novel Targets of Chemopreventive and Chemotherapeutic Drugs	Current Cancer Drug Targets	2006	158
48	Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells	Current Cancer Drug Targets	2009	157
49	Anti-Apoptotic Mechanisms of Drug Resistance in Cancer	Current Cancer Drug Targets	2009	157
50	Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy	Current Cancer Drug Targets	2008	156

Scientometrics

Overviews

Citing Bodies

Current Cancer Drug Targets

Top Articles